当前位置: X-MOL 学术Clin. Orthop. Relat. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Clinical Orthopaedics and Related Research ( IF 4.2 ) Pub Date : 2021-10-14 , DOI: 10.1097/corr.0000000000002011
Lee D Cranmer 1, 2 , Bonny Chau 1 , Jose G Mantilla 3 , Elizabeth T Loggers 1, 2 , Seth M Pollack 1, 2 , Teresa S Kim 4 , Edward Y Kim 5 , Gabrielle M Kane 5 , Matthew J Thompson 6 , Jared L Harwood 6 , Michael J Wagner 1, 2
Affiliation  

Dedifferentiated chondrosarcoma is a chondrosarcoma subtype associated with high rates of recurrence and a poor prognosis. Others have proposed treatment of dedifferentiated chondrosarcoma using osteosarcoma protocols, including perioperative chemotherapy. However, the rarity of this condition poses difficulties in undertaking single- institution studies of sufficient sample size.

中文翻译:

化疗与去分化软骨肉瘤患者总体生存率的提高有关吗?SEER 数据库分析。

去分化软骨肉瘤是一种与高复发率和不良预后相关的软骨肉瘤亚型。其他人建议使用骨肉瘤方案治疗去分化软骨肉瘤,包括围手术期化疗。然而,这种情况的罕见性给进行足够样本量的单一机构研究带来了困难。
更新日期:2021-10-14
down
wechat
bug